Status: Recruiting
A Study of YP05002 in Healthy Participants
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of YP05002 Tablets in healthy participants
Participants needed: 76
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Yaopharma Co., Ltd.Updated: Aug 6, 2025Locations: 1
Eligibility criteria
Willing and able to comply with all scheduled visits, treatment plan, laboratory... [+2]
Have evidence of any clinically significant active or chronic disease. [+4]